William Mayer Garneau MD
Addiction Medicine, Hospital Medicine/Hospitalist
RESIDENT AT JOHNS HOPKINS
Join to view full profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Garneau is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 2017 - 2019
University of North Carolina at Chapel Hill School of MedicineClass of 2016
Certifications & Licensure
CA State Medical License 2020 - 2028
MD State Medical License 2019 - 2026
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Patient-Directed Discharge Among Hospitalized Persons With Opioid Use Disorder in the Fentanyl Era: A Scoping Review.William M Garneau, Severyn Kushmeliuk, Dustin P Kee, Kelly A Gebo, Megan E Buresh
American Journal of Medicine Open. 2026-06-01 - 1 citationsMethadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder.Rebecca R Meredith, William M Garneau, Kenneth A Feder, Megan E Buresh
JAMA Network Open. 2026-03-02 - Challenges With Buprenorphine Initiation in the Fentanyl Era-Adapting Effectively to the Moment.William M Garneau, Eric C Strain, Michael I Fingerhood
JAMA Network Open. 2026-01-02
Press Mentions
Center for Innovative Medicine Next Generation ScholarsJune 13th, 2025- COVID-19 Drug Paxlovid Safe for Use During Pregnancy, Study SaysDecember 12th, 2022
- Paxlovid Safe for Pregnant Patients with COVID-19December 9th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
